PL-3994

· Palatin Technologies, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PL-3994, covering 2013-06-21 to 2025-12-15. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Sex Differences in the Acute Effects of PL-3994 in Heart Failure Subjects [Phase 2]